Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.
Endoscopic Ultrasound (EUS) is an equipment where an ultrasound transducer is attached to the tip of the endoscope. When advanced to the stomach the organs outside such as the pancreas and liver can be visualized in great detail. This enables diagnosis of conditions such as pancreatic cancer. However, an endoscopist must undergo training to accurately interpret these ultrasound images.
The investigators are in the process of developing an artificial intelligence system that could potentially interpret EUS images. The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures. Such correlation if established will lead to possible development of an artificial intelligence platform that can diagnose pancreatic diseases. Such development will potentially minimize human error and decrease learning curve to gain proficiency in EUS.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients undergoing endoscopic ultrasound procedures | Patients will undergo endoscopic ultrasound procedures as planned. Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Patients undergoing endoscopic ultrasound procedures | Device | Patients will undergo endoscopic ultrasound procedures as planned. Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform. |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of detection pancreatic abnormalities by AI | Ability of AI to detect pancreatic abnormalities as identified by an endoscopist during EUS examination of the pancreas. | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of detection pancreatic solid mass lesions by AI | Ability of AI to detect pancreatic solid mass lesions as identified by an endoscopist during EUS examination of the pancreas. | 1 day |
| Rate of detection pancreatic cystic lesions by AI |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Any patient 18 years or over undergoing endoscopic ultrasound examination
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Shyam Varadarajulu, MD | Contact | 321-841-2431 | shyam.varadarajulu@orlandohealth.com | |
| Barbara Broome | Contact | 321-841-4356 | barbara.broome@orlandohealth.com |
| Name | Affiliation | Role |
|---|---|---|
| Shyam Varadarajulu, MD | Orlando Health, Digestive Health Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Orlando Health | Recruiting | Orlando | Florida | 32806 | United States |
Not provided
| ID | Term |
|---|---|
| D010190 | Pancreatic Neoplasms |
| D010182 | Pancreatic Diseases |
| D010181 | Pancreatic Cyst |
| ID | Term |
|---|---|
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004701 | Endocrine Gland Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
|
Ability of AI to detect pancreatic cystic lesions as identified by an endoscopist during EUS examination of the pancreas.
| 1 day |
| D004066 |
| Digestive System Diseases |
| D004700 | Endocrine System Diseases |
| D003560 | Cysts |